Reduced COVID-19 Hospitalizations among New York City Residents Following Age-Based SARS-CoV-2 Vaccine Eligibility: Evidence from a Regression Discontinuity Design Author(s): Greene SK, Levin-Rector A, McGibbon E, Baumgartner J, Devinney K, Ternier A, Sell J, Kahn R, Kishore N|Journal: Vaccine X|PMID: 34961848| December 2021 In clinical trials, several SARS-CoV-2 vaccines were shown to reduce risk of severe COVID-19 illness. Local, population-level, real-world evidence of…
